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Abstract
Background: Magnetization transfer saturation (MTsat) imaging was developed to reduce T1
dependence and improve specificity to myelin compared to the widely used MT ratio (MTR),
while maintaining a feasible scan time. Knowledge of MTsat reproducibility is necessary to
apply MTsat in preclinical neuroimaging.
Purpose: To assess the test-retest reproducibility of MTR and MTsat in the mouse brain at 9.4 T
and calculate sample sizes required to detect various effect sizes.
Study Type: Prospective
Animal Model: C57Bl/6 Mouse Model (6 females and 6 males, aged 12 – 14 weeks)
Field Strength/Sequence: Magnetization Transfer Imaging at 9.4 T
Assessment: All mice were scanned at two timepoints (5 days apart). MTR and MTsat maps
were analyzed using mean region-of-interest (ROI), and whole brain voxel-wise analysis.
Statistical Tests: Bland-Altman plots assessed biases between test and retest measurements.
Test-retest reproducibility was evaluated via between and within-subject coefficients of variation
(CV). Sample sizes required were calculated (at a 95 % significance level and power of 80 %),
given various minimum detectable effect sizes, using both between and within-subject
approaches.
Results: Bland-Altman plots showed negligible biases between test and retest sessions. ROIbased and voxel-wise CVs revealed high reproducibility for both MTR (ROI: CVs < 8 %) and
MTsat (ROI: CVs < 10 %). With a sample size of 6, changes on the order of 15% can be detected
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in MTR and MTsat, both between and within subjects, while smaller changes (6 – 8 %) require
sample sizes of 10 – 15 for MTR, and 15 – 20 for MTsat.
Data Conclusion: MTsat exhibits comparable reproducibility to MTR, while providing
sensitivity to myelin with less T1 dependence than MTR. Our findings suggest both MTR and
MTsat can detect moderate changes, common in pathologies, with feasible preclinical sample
sizes.
Keywords: magnetization transfer ratio, magnetization transfer saturation, reproducibility,
preclinical rodent imaging
INTRODUCTION
Magnetization transfer (MT) imaging has been used extensively to investigate changes in
myelin content and integrity in brain development, injury and white matter diseases, most
notably in multiple sclerosis patients.1,2 MT imaging applications include both conventional
contrast-weighted protocols (such as magnetization transfer ratio, MTR) and quantitative MT
(qMT) methods.3
MT is a physical process by which macromolecules and their closely associated water
molecules cross-relax with protons in the free water pool.4 Based on this phenomenon, it is
possible to quantify the protons bound to large molecules, which are not MR visible, due to their
extremely short transverse relaxation time (T2).5 MT contrast can be generated by applying an
off-resonance radiofrequency pre-pulse (MT pulse) to selectively saturate the spectrally broad
macromolecular proton pool. This saturation then transfers to the free water proton pool via MT,
resulting in a decrease in the observed free water signal. The magnitude of the MT effect can be
characterized by the magnetization transfer ratio (MTR):

bioRxiv preprint doi: https://doi.org/10.1101/2021.12.10.472129; this version posted December 13, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY 4.0 International license.

MTR 




(1)

where PDw is the signal without an MT pulse applied, which is proton density weighted (PDw),
and MTw is the signal with the MT pulse applied, which is MT weighted (MTw). Although
MTR has been shown to correlate well with histological myelin content,1,6 it is also sensitive to
the choice of sequence parameters, flip angle inhomogeneities, and longitudinal relaxation time
(T1).7 T1 also correlates strongly with myelin content, but is also sensitive to axon size8 and iron
content,9 mitigating the power of MTR as a measure of myelin. Quantitative MT has been used
in many recent works to quantity myelin,10–14 as it reduces the confounding effects of scan
parameters and quantifies specific tissue characteristics, such as the macromolecular pool size.5
However, qMT relies on complex modeling of the MR signal dependence on myelin, and
requires more measurements and thus longer acquisition times compared to contrast-weighted
MT protocols.15
Magnetization transfer saturation (MTsat) imaging was developed to improve MTR, by
decoupling MTR from T1 effects, while maintaining a feasible scan time.7 The shorter scan time
compared to qMT enables longitudinal in vivo imaging and allows the addition of other imaging
techniques required to characterize microstructure. A scalar map of MTsat can be acquired using
two reference scans of proton density and T1 weighting (PDw and T1w respectively), and one
MTw scan. MTsat, being more independent of system parameters and T1 weighting, and less
susceptible to inhomogeneities of the receiver coil and the transmitted RF field, provides greater
specificity and contrast compared to MTR.7,16 MTsat shows higher white matter contrast in the
brain than MTR,7 and has been shown to correlate more with disability metrics than MTR in
patients with multiple sclerosis.17 Hagiwara et al. reported that MTsat may be more suited to
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measure myelin in the white matter, compared to the ratio of T1-weighted to T2-weighted
images, which has also been proposed as a measure of myelin.18
There is strong interest in applying MT to preclinical rodent neuroimaging studies at
ultra-high field strengths, demonstrated by MTR19–22 and qMT studies.13,23–25 The feasibility of
MTsat in mice at 9.4 T has been shown previously26 and MTsat has been explored in a feline
model of demyelination at 3 T.27 Although most MTsat studies have been performed at 3 T,
recently, Olsson et al. reported an optimized whole-brain MTsat protocol at 7 T,28 which
highlights the increasing interest in this method. In vivo studies of MTsat in humans at 3 T have
shown high reproducibility.29,30 However, to our knowledge, there are no test-retest
reproducibility studies of MTsat or applications of MTsat to animal models of disease/injury at
ultra-high field strength. Moreover, there are no studies comparing MTR and MTsat
reproducibility. As MTsat provides a time-efficient alternative to fully quantitative techniques
but with increased specificity and contrast compared to MTR, investigation of MTsat in
preclinical rodent imaging will likely be of interest to other research groups. The aim of this
work was to assess test-retest reproducibility of in vivo MTR and MTsat in mice at 9.4 Tesla and
provide estimates of required sample sizes, which is essential in planning preclinical
neuroimaging studies involving models of disease/injury.
METHODS
Subjects
All animal procedures were approved by the University of Western Ontario Animal Use
Subcommittee and were consistent with guidelines established by the Canadian Council on
Animal Care. Twelve adult C57Bl/6 mice (six males and six females) were scanned twice 5 days
apart. The sample size was chosen to reflect similar sample sizes used in other pre-clinical
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imaging studies.31–34 Before scanning, anesthesia was induced by placing the animals in an
induction chamber with 4 % isoflurane and an oxygen flow rate of 1.5 L/min. Following
induction, isoflurane was maintained during the imaging session at 1.8 % with an oxygen flow
rate of 1.5 L/min through a custom-built nose cone. The mouse head was fixed in place using ear
bars and a bite bar to prevent head motion. These mice were part of a longitudinal study, at the
end of which they were euthanized for histology. The mice were anesthetized with
ketamine/xylazine (2:1) and then underwent trans-cardiac perfusion with ice-cold saline,
followed by 4% paraformaldehyde in phosphate-buffer saline (PBS).
In vivo MRI
In vivo magnetic resonance imaging (MRI) experiments were performed on a 9.4 Tesla
(T) Bruker small animal scanner equipped with a gradient coil set of 1 T/m strength (slew rate =
4100 T/m/s). A single channel transceive surface coil (20 mm x 25 mm), built in-house, was
fixed in place directly above the mouse head to maximize signal-to-noise ratio (SNR). A boost in
SNR in the cortex when using this surface coil, compared to a commercially available 40-mm
millipede (MP40) volume coil (Agilent, Palo Alto, CA, USA), has been reported previously.35
The MT protocol required 50 minutes total scan time and comprised three FLASH-3D
(fast low angle shot) scans, and one RF transmit field (B1) map scan to correct for local
variations in flip angle. An MT-weighted scan, and reference T1-weighted and PD-weighted
scans (MTw, T1w, and PDw respectively) were acquired by appropriate choice of the repetition
time (TR) and the flip angle (α): TR/α = 8.5 ms/20° for the T1w scan and 25 ms/9° for the PDw
and the MTw scans. MT-weighting was achieved by applying an off-resonance Gaussian-shaped
RF pulse (12 ms duration, 385° nominal flip angle, 3.5 kHz frequency offset from water
resonance, 5 µT RF peak amplitude) prior to the excitation. Other acquisition parameters were:
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TE = 2.75 ms; resolution = 150x150x400 µm3; field of view (FOV) = 19.2 x 14.4 x 12 mm3;
read-out bandwidth = 125 kHz; 12 averages. The B1 map was acquired acquired based on the
actual flip angle imaging (AFI) method36 at a lower resolution of 600x600x400 um3 and the
following scan parameters: TE = 4 ms; α = 60°; short TR = 20 ms; long TR = 100 ms; 2
averages. Anatomical images were also acquired for each subject within each session using a 2D
T2-weighted TurboRARE pulse sequence (150 μm in-plane resolution; 500 μm slice thickness;
TE/TR = 40/5000 ms; 16 averages; total acquisition time = 22 min).
Image Processing
MTR and MTsat maps were generated using in-house MATLAB code. Gaussian filtering
(full-width-half-maximum = 3 voxels) was first applied to the original images (MTw, PDw, and
T1w images, and B1 maps) to reduce noise, while retaining image contrast. The standard MTR
maps were calculated using Equation (1). MTw, PDw, and T1w images were used to calculate
MTsat maps, following the original method proposed by Helms et al.,7 and outlined by Hagiwara
et al.18 MTsat is inherently robust against differences in relaxation rates and inhomogeneities of
RF transmit and receive field compared with conventional MTR imaging.7,16 Furthermore, B1
maps were used to correct for small residual higher-order dependencies of the MT saturation on
the local RF transmit field to further improve spatial uniformity, as suggested by Weiskopf et
al.29:
౦౦ ·  .
MTsat   .·
ౢౙౢ

(2)

where RFlocal is the relative flip angle α compared to the nominal flip angle, and MTsatapp is the
uncorrected apparent MTsat. RFlocal was calculated based on the AFI method.36
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Brain masks were produced using the skull stripping tool from BrainSuite (v. 19b).37
Image registration was performed using affine and symmetric diffeomorphic transforms with
ANTs software (https://github.com/ANTsX/ANTs).38 Region-of-interest (ROI) masks were
acquired from the labeled Allen Mouse Brain Atlas.39 Since registration to an atlas is timeconsuming, only one anatomical T2-weighted scan was chosen (the “chosen T2”) to be
registered to the atlas. All other anatomical T2-weighted images were registered to the chosen
T2. MTR parameter maps were registered to the corresponding anatomical images (from the
same subject at the same timepoint). For ROI-based analysis, the inverse transforms resulting
from these three registration steps (MTR

corresponding T2

chosen T2

atlas) were then

used to bring the labeled atlas to the corresponding MT space for each subject at each timepoint.
Binary masks for each ROI were generated by thresholding the labeled atlas. Each mask was
eroded by one voxel, except for the corpus callosum masks, to minimize partial volume errors
within a given ROI. The binary masks were visually inspected to ensure good registration
quality.
Furthermore, to perform whole brain voxel-wise analysis of all subjects across both
timepoints, the data was registered to a common template. MTR maps were first registered to
one MTR map (the “chosen MTR”). All MTsat maps were then registered to the chosen MT
space using a single transform: MTR

chosen MTR. For voxel-wise analysis targeted to

specific ROIs, the labeled atlas was registered to the chosen MT space.
Data Availability
The test-retest dataset and in-house code to compute MTR and MTsat is available
online.40
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Data Analysis
ROI-based and Voxel-wise Analysis
ROI analysis was performed using two approaches: (1) analysis of unregistered data and
(2) analysis of data registered to a common template. For the second approach, all MTR and
MTsat maps were registered to a “chosen” MTR space, as described above.
The ROI analysis focused on five different tissue regions: corpus callosum (CC), internal
capsule (IC), hippocampus (HC), cortex (CX), and thalamus (TH). For both ROI-based
approaches, Bland-Altman and CV analyses were performed using the mean MTR and MTsat
values from each ROI. Voxel-wise CV analysis was also performed with the registered data.
Statistical Analysis
Measurement reproducibility was explored for both ROI-based analysis and whole brain
voxel-wise analysis, since both are common analysis techniques in neuroimaging. To mitigate
partial volume errors from cerebrospinal fluid (CSF) in ROI-based analysis, voxels with MTR <
0.1 were omitted in both test and retest images. In voxel-wise analysis, voxels with MTR < 0.1,
as measured on the test images, were omitted. Bland-Altman analysis was performed for the
ROI-based analyses to identify any biases between test and retest measurements. For both
analysis techniques, the scan-rescan reproducibility was characterized using the coefficient of
variation (CV). The CV reflects both the reproducibility and variability of these metrics, as well
as provides insight into necessary sample sizes and minimum detectable effect size. CVs were
calculated between subjects and within subjects to quantify the between subject and within
subject reproducibility, respectively. The between subject CV was calculated separately for the
test and retest timepoints as the standard deviation divided by the mean value across subjects 1–
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12. These two CV values were then averaged for the mean between subject CV. The within
subject CV was calculated separately for each subject as the standard deviation divided by the
mean of the test and retest scans. The 12 within subject CVs were then averaged to determine the
mean within subject CV.
Sample size calculations were performed based on CVs from the ROI analysis of
registered data. Minimum sample sizes required to detect defined biological effects, using both
between and within subject approaches, were determined at a 95 % significance level (α = 0.05)
and power of 80 % (1−β = 0.80). Following the procedure presented in van Belle,41 the between
subject CVs were used to determine the sample size required per group to detect a defined
biological effect between subjects in each ROI. Assuming paired t-tests, the standard deviations
of the differences between test-retest mean values across subjects, were used to determine the
sample size required to detect a defined biological effect within subjects in each ROI.42
RESULTS
Parameter Maps
Representative parameter maps are shown in Figure 1. MTsat is comparable to MTsat
maps acquired by Boretius et al. in the mouse brain at 9.4 T26 and reveals slightly greater
contrast than MTR between gray matter and white matter, which is noticeable when comparing
the corpus callosum and internal capsule (white matter regions) to the surrounding gray matter.
ROI-based Analysis
Violin plots depict the distribution of the mean values for each metric within each ROI
for the 12 subjects for both registered and unregistered datasets (Figure 2). Across all metrics,
the median and interquartile range are similar for test and retest conditions and results are
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comparable for registered and unregistered datasets. In general, the smaller ROIs (i.e., the
internal capsule) showed greater distributions, while the larger ROIs (i.e., the cortex) showed
much tighter distributions.
Bland-Altman (BA) plots revealed negligible biases for MTR and MTsat (Figure 3).
MTR exhibited lower between and within subject CVs (4.5 – 8 %) compared to MTsat (6 – 10
%), as shown in Figure 4. In general, CVs are comparable across all ROIs. These trends are
comparable across both registered and unregistered data.
Voxel-wise Analysis
The voxel-wise CV maps show very high CVs in the cerebrospinal fluid (CSF), due to
the low values of MTR and MTsat in the CSF (Figure 5). Between and within subject CVs are
stable throughout the whole brain, with the within subject CVs being slightly lower than the
between subject CVs. As observed in the ROI-based CVs, MTR exhibited lower between and
within subject CVs (with peaks at 7 % and 6 %, respectively) compared to MTsat (with peaks at
15 % and 12 %, respectively), as shown in whole brain histograms (Figure 6). The MTsat
histograms also revealed a wider distribution compared to the MTR histograms.
Sample sizes and minimum detectable effect
Between subjects
The between subject CVs, from the ROI analysis, were used to determine the minimum
sample sizes required to detect statistically significant changes of 6, 8, 10, 12 and 14 % between
subjects in each metric within each ROI. To detect a minimum change of 8 % in all ROIs, MTR
required a sample size of 15 (Figure 7). In comparison, MTsat required a sample size of 25 to
detect an 8 % change in all ROIs. The CC and CX required smaller sample sizes, with MTR
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requiring 12 subjects to detect a 6 % change, and MTsat requiring 15 subjects to detect an 8 %
change.
Within subjects
The standard deviations of the differences between test-retest mean values across subjects
(assuming paired t-tests) were used to determine the minimum sample sizes required to detect
statistically significant changes of 6, 8, 10, 12, and 14 % within subjects in each metric within
each ROI. In the CC and CX, minor changes (6 %) can be detected in MTR with 6 subjects per
group, while MTsat could detect larger changes (8 – 12 %) with 12 subjects per group. For MTR,
small changes (6 %) could be detected in the other ROIs (IC, HC, TH) with a feasible sample
size of 15. MTsat can detect larger changes (8 % and greater) in all ROIs with 20 subjects per
group.
DISCUSSION
This study explores the reproducibility of MTR and MTsat at 9.4 T. No biases were
found between repeat measurements with ROI-based analysis. MTR and MTsat were shown to
be reproducible in both the mean ROI analysis and the whole brain voxel-wise analysis, with
MTsat CVs being slightly higher than MTR CVs. Overall, within subject CVs were lower than
between subject CVs for both ROI-based and voxel-wise analysis, indicating less variability
within subjects on a test-retest basis.
ROI-based Reproducibility
ROI-based reproducibility was investigated using an unregistered dataset and a dataset
registered to a common template, as both unregistered and registered analysis techniques have
been used in neuroimaging studies, and the difference between using either analysis technique
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remains sparsely explored. Recently, Klingenberg et al. reported that registration significantly
increased the accuracy of a convolutional neural network (CNN) to detect Alzheimer’s disease,
compared to no registration.43 Violin plots, BA plots, and ROI-based CV analysis reveal the
same trends for both registered and unregistered ROI-based analysis approaches, which indicates
that either method can be used for MT analysis. However, we recommend using the registered
analysis approach, as there is only one set of ROI masks to edit, making the analysis process
more time efficient. The unregistered analysis approach will also introduce inter- and intra-rater
variability, due to the large number of ROI masks being edited.
The MTR ROI CVs observed in this work are consistent with MTR CVs in human studies
done by Welsch et al.44 and Hannila et al.45 MTsat CVs reported here are comparable to MTsat
CVs in human studies at 3 T.29,30 Overall, MTsat exhibits slightly higher CVs than MTR, which
may arise from noise propagation through the equations used to calculate MTsat, as described by
Olsson et al.28 A noticeable increase in MTsat CVs compared to MTR CVs, in the HC and CX,
may be due to low MTsat values in these regions.
Voxel-wise Reproducibility
Voxel-wise CV trends were comparable to ROI-based CV trends. Voxel-wise CV maps
revealed a more noticeable increase in CVs in the superior-inferior direction of the brain in
MTR, compared to MTsat. This can be related to the inherent compensation of flip angle
inhomogeneities in MTsat.
Sample Size and Minimum Detectable Effect
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Given the current test-retest study design, small changes (6 - 8 %) can be detected in
MTR and MTsat, both between and within subjects, with feasible sample sizes of 10 – 15 for
MTR, and 15 – 20 for MTsat. With a sample size of 6, moderate changes (~15 %) can be
detected in MTR and MTsat, both between and within subjects, in all ROIs. The CC consistently
exhibited the smallest required sample sizes, which can be related to the lower variability of
myelin content in the CC, compared to the gray matter ROIs.46 Interestingly, the CC and IC (the
white matter regions) require similar sample sizes to detect the same changes in MTsat (using
both between and within subject approaches), but not in MTR, which requires larger sample
sizes to detect changes in IC. This may stem from the better contrast seen between the IC and
gray matter in MTsat, compared to MTR, which arises from MTsat being less susceptible to
inhomogeneities of the transmitted field and more independent of T1-weighting.7,26 Most MT
studies report changes in MTR between 15 – 30 %, with some studies reporting more subtle
changes between 5 – 10 %. In a cuprizone demyelination model in mice, MTR decreased by 15
% and 30 % at 4 weeks and 6 weeks of cuprizone administration, respectively.47 In an ischemic
injury model in mice, MTR decreased by 30 % in the corpus callosum of injured mice compared
to controls.21 In a closed head traumatic brain injury model in mice, MTR in the corpus callosum
decreased by 10 % from baseline at 1-day post-injury.20 A post-mortem study revealed a 10 %
decrease in MTR between normal-appearing white matter and multiple sclerosis lesions.1 In a
recent multiple sclerosis study, MTR was able to differentiate between patients with and without
cognitive impairment, showing a 7 % decrease in patients with cognitive impairment.48
MTR can detect changes on the order of 15 - 30 % (such as the changes found in the
cuprizone demyelination model) with small sample sizes (n = 6). With disease and injury models
resulting in less drastic changes to myelin content, our findings suggest that MTR and MTsat can
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detect smaller changes with feasible preclinical sample sizes. Thiessen et al.47 showed that when
there's an 80% reduction in myelinated axon density, MTR only decreases by ~ 30 % (because
it's thought that inflammation has a competing effect on MTR). So, a two-fold difference in
myelination will result in at least a 15 % change in MTR. However, as MTsat provides greater
specificity to myelin, a two-fold difference in myelination should translate to a larger percent
change in MTsat.
Limitations
Although a volume coil is more appropriate for structural imaging as it provides stable
signal-to-noise ratio throughout the brain, this study used a transceive surface coil. The voxelwise CV maps show that between-subject and within-subject CVs are slightly higher towards the
inferior region of the brain. However, the increase in CV is subtle and as shown in ROI-based
analysis, the CVs of ROIs located in inferior regions of the brain (such as the IC) are comparable
to the ROIs closer to the surface coil. This shows the feasibility of acquiring MTR and MTsat
data using a surface coil, which may be useful in studies in which MT imaging is combined with
other methods that require a surface coil or inherently low SNR methods that would benefit from
a surface coil, such as diffusion MRI. Recent preclinical investigations have included a
combination of MT imaging and diffusion MRI.20,25,49 Moreover, the findings in this study will
complement a recent test-retest reproducibility study in advanced diffusion MRI techniques in
mice at 9.4 T.35
In the statistical analyses, it should be noted that for the within-subject calculation of CV,
the standard deviation was determined from only two data points (the test and retest conditions).
As a result, the standard deviation may not accurately represent the spread of data within the
population, leading to an unknown bias in the resulting within-subject CV.

bioRxiv preprint doi: https://doi.org/10.1101/2021.12.10.472129; this version posted December 13, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY 4.0 International license.

CONCLUSION
In conclusion, we have investigated the reproducibility of MTR and MTsat in a rodent
model at an ultra-high field strength. We have shown that MTR and MTsat are reproducible in
both ROI-based analysis, which includes both registered and unregistered analysis techniques,
and voxel-wise analysis. Importantly, MTsat exhibits comparable reproducibility to MTR, while
providing better contrast. With a sample size of 6, changes on the order of 15% can be detected
in MTR and MTsat, both between and within subjects, while smaller changes (6 – 8 %) require
feasible sample sizes of 10 – 15 for MTR, and 15 – 20 for MTsat. This work will provide insight
into experiment design and sample size estimation for future longitudinal in vivo MTsat imaging
studies at 9.4 T.
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FIGURES

Figure 1. Example axial cross sections from a single subject. An anatomical T2-weighted
image, an MT weighted (MTw) image, reference T1 weighted (T1w) and proton density
weighted (PDw) images, a B1 map, and corresponding MTR and MTsat maps are shown. ROIs
analyzed are overlaid on an MTw image and abbreviated as follows: CC – corpus callosum; IC –
internal capsule; HC – hippocampus; CX – cortex; TH – thalamus.
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Figure 2. Violin plots showing the distribution of MTR and MTsat at the test and retest
timepoints (five days apart) for 12 subjects in several brain regions. Unregistered data (left
column) and data registered to a common template (right column) are shown. The dark black line
represents the median and the red lines depict the interquartile range (25th to 75th percentile). The
violin plots extend to the minimum and maximum values of each metric. ROIs are abbreviated as
follows: CC – corpus callosum; IC – internal capsule; HC – hippocampus; CX – cortex; TH –
thalamus.
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Figure 3. Bland-Altman plots depicting biases between test and retest scans for mean MTR
and MTsat values (from the ROI-based analysis). Unregistered data (left column) and data
registered to a common template (right column) are shown. The solid black lines represent the
mean bias, and the dotted black lines represent the ±1.96 standard deviation lines. The average of
the test and retest mean values is plotted along the x-axis and the difference between the test and
retest mean values is plotted along the y-axis. ROIs in the legend are abbreviated as follows: CC
– corpus callosum; IC – internal capsule; HC – hippocampus; CX – cortex; TH – thalamus.
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Figure 4. Mean between subject and within subject coefficients of variation (CV) for MTR
and MTsat in each ROI. Reproducibility metrics for unregistered data (left column) and data
registered to a common template (right column) are shown. Values for the between subject CV
condition represent the mean ± standard deviation over subjects (averaged over the test and retest
timepoints). Values for the within subject CV condition represent the mean ± standard deviation
between test and retest (averaged over the 12 subjects). ROIs are abbreviated as follows: CC –
corpus callosum; IC – internal capsule; HC – hippocampus; CX – cortex; TH – thalamus.
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Figure 5. Voxelwise average between subject and within subject CV maps for MTR (top
row) and MTsat (bottom row). Values for the between subject condition represent the mean
CV within each voxel averaged over the test and retest timepoints. Values for the within subject
condition represent the mean CV within each voxel averaged over all 12 subjects. ROIs are
abbreviated as follows: CC – corpus callosum; IC – internal capsule; HC – hippocampus; CX –
cortex; TH – thalamus.
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Figure 6. Distribution of whole brain voxel-wise between and within subject CVs for MTR
and MTsat.
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Figure 7. Sample size estimation using a between-subjects approach on data registered to a
common template. Sample sizes required, calculated from ROI-based between-subject CVs, to
detect a statistically significant effect within each ROI with a change in each metric of 6, 8, 10,
12, and 14 %. Note that the sample size range varies between plots and sample sizes exceeding
the range are not shown. ROIs are abbreviated as follows: CC – corpus callosum; IC – internal
capsule; HC – hippocampus; CX – cortex; TH – thalamus.
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Figure 8. Sample size estimation using a within-subjects approach on data registered to a
common template. Sample sizes required, calculated from the standard deviation of differences
between test-retest mean values across subjects (assuming paired t-tests), to detect a statistically
significant effect within each ROI with a change in each metric of 6, 8, 10, 12, and 14 %. Note
that the sample size range varies between plots and sample sizes exceeding the range are not
shown. ROIs are abbreviated as follows: CC – corpus callosum; IC – internal capsule; HC –
hippocampus; CX – cortex; TH – thalamus.

